Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 16, 2011 12:21 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma to Present at Noble Financial Capital Markets' Annual Equity Conference

PHILADELPHIA, May 16, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that its Senior Advisor to the CEO, Wayne Pambianchi, will...
May 12, 2011 13:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma's Ampligen(R) Cited at Barcelona Vaccine & Active Immunotherapeutics Forum 2011

PHILADELPHIA, May 12, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that Ampligen® will be featured in a discussion of...
May 06, 2011 16:55 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2011

PHILADELPHIA, May 6, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced its financial results for the three months ended March 31, 2011. The net loss for the period was...
April 04, 2011 08:00 ET | Source: Hemispherx Biopharma, Inc.

Animal Model Data Presented at AACR Indicate That Hemispherx Biopharma's Ampligen(R) May be a Potent Tumor Vaccine Adjuvant

PHILADELPHIA, April 4, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced new data presented yesterday at the American Association for Cancer Research ("AACR") 102nd Annual...
March 31, 2011 09:56 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. to Host 2010 Year End Conference Call on Wednesday, April 6, 2011

PHILADELPHIA, March 31, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") has scheduled a conference call and audio webcast on Wednesday, April 6, 2011 at 10:00 AM...
March 29, 2011 13:21 ET | Source: Hemispherx Biopharma, Inc.

Hemisphrex Biopharma Announces Fiscal 2010 Year Results

PHILADELPHIA, March 29, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced its financial results for the fiscal year ended December 31, 2010. The net loss for the year (including...
March 22, 2011 14:26 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Reports on Annual Stockholder Meeting

PHILADELPHIA, March 22, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced that it held its 2010 Annual Meeting of Stockholders on March 17, 2011. Final voting results will be...
March 07, 2011 14:25 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces 9th Clinical Investigators Conference: Ampligen Clinical Trials Highlighted

PHILADELPHIA, March 7, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) ("Hemispherx" or the "Company") announced that the Company conducted its 9th Clinical Investigators Conference...
March 03, 2011 10:00 ET | Source: Hemispherx Biopharma, Inc.

Chronix Biomedical and Hemispherx Biopharma Jointly File Patent Application for a Blood Test for Chronic Fatigue Syndrome (CFS)

Chronix Technology Focuses on Changes to CFS Patients' DNA Hemispherx and Chronix Plan Studies to Validate Technology as a Potential Diagnostic Test for CFS SAN JOSE, Calif., March 3, 2011...
February 24, 2011 08:00 ET | Source: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Annual Meeting Set

PHILADELPHIA, Feb. 24, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") will hold its annual meeting of stockholders on Thursday, March 17, 2011, at 10 a.m. EST, in...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right